Leukemias/lymphomas/ And Other Hematologic Cancers Archives - Page 66 of 67 - MPR

Leukemias/lymphomas/ And Other Hematologic Cancers

Istodax Gains Indication for T-cell Lymphoma

Celgene Corporation announced that the FDA has granted accelerated approval for its supplemental New Drug Application (sNDA) for an additional indication for Istodax (romidepsin injection): the treatment of peripheral T-cell lymphoma (PTCL) in patients who have received at least one prior therapy.

BLAs Accepted for Brentuximab Vedotin

Seattle Genetics announced that the FDA has accepted for filing two Biologics License Applications (BLAs) for brentuximab vedotin, including one for the treatment of patients with relapsed or refractory Hodgkin lymphoma and one for relapsed or refractory systemic anaplastic large cell lymphoma.